Invited contribution to the volume: "Stem cells & cancer stem cells, regenerative medicine & cancer" (VSI stem cells) reprogramming and transdifferentiation - two key processes for regenerative medicine. Eur J Pharmacol. 2020:173202..
Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. Eur J Pharmacol. 2020:173263.
Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resist Updat. 2019;42:35-45.
Could drugs inhibiting the mevalonate pathway also target cancer stem cells?. Drug Resist Updat. 2016;25:13-25.